Enterofuril suspension. 200mg / 5ml fl. 90ml
Category
Preparations for the gastrointestinal tract
,
Diarrhea
Scope of the drug
General
Release form
Oral suspension
Manufacturer country
Bosnia and Herzegovina
Package quantity, pcs
one
Release form, composition and packaging
?
Suspension for oral administration is yellow, with a banana smell.
5 ml
nifuroxazide 200 mg
sucrose - 1000 mg, sodium hydroxide - 2 mg, methyl parahydroxybenzoate - 5 mg, ethanol 96% - 0.05 ml, carbomer - 10.5 mg, citric acid - 0.75 mg, banana flavor - 10 mg, water - up to 5 ml.
90 ml - dark glass bottles (1) complete with a measuring spoon - cardboard packs.
pharmachologic effect
Broad-spectrum antimicrobial drug derived from 5-nitrofuran. Blocks the activity of dehydrogenases and inhibits the respiratory chain, the tricarboxylic acid cycle and a number of other biochemical processes in the microbial cell. Destroys the membrane of a microbial cell, reduces the production of toxins by microorganisms. Highly active against Campylobacter jejuni, Escherichia coli, Salmonella spp., Clostridium perfringens, Vibrio cholerae, pathogenic Vibrions and Vibrio parahaemolyticus, Staphylococcus spp. Weakly sensitive to nifuroxazide: Klebsiella spp., Proteus mirabilis, Providencia indologenes. Resistant to nifuroxazide: Klebsiella spp., Proteus mirabilis, Providencia spp., Pdeudomonas spp. Does not disturb the balance of intestinal microflora. In case of acute bacterial diarrhea, it restores intestinal eubiosis.When infected with enterotropic viruses, it prevents the development of bacterial superinfection.
Pharmacokinetics
After oral administration, nifuroxazide is practically not absorbed from the digestive tract and exhibits its antibacterial effect exclusively in the intestinal lumen.
Nifuroxazide is excreted by the intestines.
Indications for use
- acute bacterial diarrhea, proceeding without deterioration of the general condition, fever, intoxication.
Contraindications for use
- hypersensitivity to drug components or other nitrofuran derivatives
- fructose intolerance
- syndrome of glucose-galactose malabsorption or deficiency of sucrase and isomaltase
- pregnancy
- age up to 1 month, premature newborns (oral suspension)
- children under 3 years of age (capsules).
Dosage regimen
Is taken internally. Capsules 100 mg Adults and children over 7 years old: 2 capsules 4 times / day (200 mg 4 times / day). The daily dose is 800 mg. Children aged 3 to 7 years: 2 capsules 3 times / day (200 mg 3 times / day). The daily dose is 600 mg. Capsules 200 mg Adults and children over 7 years old: 1 capsule 4 times / day (200 mg 4 times / day). The daily dose is 800 mg. Children aged 3 to 7 years: 1 capsule 3 times / day (200 mg 3 times / day). The daily dose is 600 mg. Suspension for oral administration For dosing, a 5 ml measuring spoon with a graduation of 2.5 ml is used. Shake the suspension well before use. Children aged 1 to 6 months: 2.5 ml of the suspension 2-3 times / day with an interval of 8 to 12 hours. Children from 7 months to 3 years: 2.5 ml of the suspension 3 times / day with an interval of 8 hours. 3 to 6 years old:5 ml of suspension 3 times / day with an interval of 8 hours.Children aged 6 to 18 years: 5 ml of suspension 3-4 times a day with an interval of 6 to 8 hours. Adults: 5 ml of suspension 4 times / day with an interval of 6 hours. The duration of the course of treatment is 5-7 days, but not more than 7 days. If there is no improvement within the first 3 days of taking, you should consult a doctor.
Overdose
Overdose symptoms are unknown.
Treatment is symptomatic.
Side effect
Allergic reactions: rash, urticaria, Quincke's edema, anaphylactic shock.
Drug interactions
Simultaneous use with drugs that cause the development of disulfiram-like reactions, drugs that inhibit the function of the nervous system is not recommended.
If you are taking other medicines (including over-the-counter medicines), consult your doctor before using the medicine.
Application during pregnancy and lactation
In animal studies was not
Name ENG
ENTEROFURYL
Clinical and pharmacological group
Intestinal antiseptic.
Antidiarrheal drug
ATX code
Nifuroxazide
Dosage
200mg / 5ml x 90ml
Structure
5 ml of oral suspension contains: active substance: nifuroxazide 200 mg.
excipients: sucrose - 1000 mg
sodium hydroxide - 2 mg
methyl parahydroxybenzoate - 5 mg
ethanol 96% - 0.05 ml
carbomer - 10.5 mg
citric acid - 0.75 mg
banana flavor - 10 mg
water - up to 5 ml
Indications
acute bacterial diarrhea, proceeding without deterioration of the general condition, fever, intoxication.
Storage conditions and periods
At a temperature of 15-30 degrees.
Expiration date: 3 years
after opening - 14 days
Contraindications
hypersensitivity to the components of the drug or other nitrofuran derivatives
intolerance to fructose
syndrome of glucose-galactose malabsorption or deficiency of sucrase and isomaltase
pregnancy
age up to 1 month, premature infants (oral suspension)
children under 3 years of age (capsules).
INN / Active ingredient
nifuroxazide
Specifications
Category
Preparations for the gastrointestinal tract
,
Diarrhea
Scope of the drug
General
Release form
Oral suspension
Manufacturer country
Bosnia and Herzegovina
Package quantity, pcs
one
Minimum age from
1 month
Way of introduction
Through the mouth
Vacation conditions
Without recipe
Brand name
Bosnalek +
Components
measuring spoon
The amount of the dosage form in the primary package
90 ml
Primary packaging type
Bottle
Type of consumer packaging
Pack of cardboard
Pharmaco-therapeutic group
Antimicrobial agent - nitrofuran
Anatomical and therapeutic characteristics
A07AX03 Nifuroxazide
Dosage form
Suspension for oral administration
Dosage (volume) of the substance in the preparation
nifuroxazide 200 mg
Expiration date in days
1095
The target audience
Children
Package weight, g
150
Mode of application
:
Inside.
Therapy with nifuroxazide should not last more than 7 days. < br> < br> For dosing, use a dosage spoon of 5 ml, which has a graduation of 2.5 ml. < br> < br> Before use, the suspension must be shaken well. < br> < br> Children 1-6 months: 2.5 ml 2-3 times a day (with an interval of 8 to 12 hours). < br> < br> Children 7 months - 2 years: 2.5 ml 4 times a day (with an interval 8 hours). < br> < br> Children 3-7 years old: 5 ml 3 times a day (with an interval of 8 hours). < br> < br> Adults and children over 7 years old: 5 ml 3-4 times a day (with an interval of 6-8 hours).
Information on technical characteristics, delivery set, country of manufacture